2005
DOI: 10.3409/173491605775142747
|View full text |Cite
|
Sign up to set email alerts
|

Implantation of Natural Hydroxyapatite from Porcine Bone into Soft Tissues in Mice

Abstract: The natural origin of hydroxyapatite (HA) derived from pig bones (Polish patent No.P-359 960 pending from 5th May 2003) was histologically examined for its biocompatibility following implantation into mouse muscles. The implanted ceramic was encapsulated by well vascularized connective tissue and very slowly resorbed by multinucleated cells. This material did not elicit an immune reaction and adjacent bones were unaffected. This ceramic could be safely used as a filling material alone, or as a composite graft.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
7
0

Year Published

2007
2007
2023
2023

Publication Types

Select...
4

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(8 citation statements)
references
References 51 publications
1
7
0
Order By: Relevance
“…In general, the results for HAp-containing samples were similar to the PLC group. Similar to our findings, there are works in which calcium phosphate ceramics introduced into areas surrounding soft tissue did not elicit an adverse reaction and was deemed safe [15][16][17]81 and even necessary for proper integration of the implant in soft tissue. 82 4.…”
Section: Resultssupporting
confidence: 90%
See 2 more Smart Citations
“…In general, the results for HAp-containing samples were similar to the PLC group. Similar to our findings, there are works in which calcium phosphate ceramics introduced into areas surrounding soft tissue did not elicit an adverse reaction and was deemed safe [15][16][17]81 and even necessary for proper integration of the implant in soft tissue. 82 4.…”
Section: Resultssupporting
confidence: 90%
“…The performed examinations proved that the tested materials undergo degradation and subsequent release of byproducts, and further, they were removed from the implantation site by known excretion paths. 61,62,67−69 Moreover, the maximum amounts of radiopaque fillers, e.g., in 10 mm-long FM (approximately 10 mg in weight), are definitely lower than when administrated clinically or tested in other scientific reports; a single dose of iodinated contrast agents during an examination of a patient is up to 200 g. 70 The content of BaSO 4 applied in well-tolerated pancreatic stents was approximately 30 mg (estimated from the geometry), 71 and the mass of HAp granules inserted into thigh muscles of mice was 10 mg. 15 The presented biodegradable FMs seemed to be attractive alternatives to commercial nondegradable FMs. Additionally, the concept of the utilization of composite materials for the fabrication of FMs has the advantage of adapting the contrasting properties for the needs.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…50 Moreover, the biocompatibility of HAP in the soft tissue surroundings was confirmed multiple times. [51][52][53] Additionally, the nanometric size of the used HAp particles ensured a large specific surface area, which provided a uniform iohexol distribution and decreased the probability of aggregation of the ICG. It is known that ICG aggregates are fluorescently ineffective 54,55 ; thus, larger surface area contributed to hindering the selfquenching effect of ICG fluorescence.…”
Section: Discussionmentioning
confidence: 99%
“…This could be expected, as the amounts of embedded fillers are also much lower than those administrated during clinical procedures or tested in other studies on their biocompatibility. 52,63,64 5 | CONCLUSION…”
Section: Discussionmentioning
confidence: 99%